Details

Last Funding Type

Grant

Last Funding Money Raised

$2M

Industries

Biotechnology,Health Care,Pharmaceutical,Therapeutics

Founded date

Jan 1, 2008

Number Of Employee

1 - 10

Operating Status

Active

Viewpoint Molecular Targeting develops radiopharmaceutical therapeutics for cancer and complementary diagnostic imaging agents that enable a personalized approach to cancer therapy.

ViewpointMT's alpha-particle radiotherapies deliver alpha radiation specifically to cancer cells utilizing specialized targeting peptides. ViewpointMT is also developing complementary diagnostics that utilize the same targeting peptide which provide the opportunity to personalize treatment and optimize patient outcomes. This "theranostic” approach enables the ability to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity associated with many other types of cancer treatments.